Sfoglia per AUTORE
GUO Y
Collezione AO Ordine Mauriziano

  

Items : 2

2024
AO Ordine Mauriziano

Hu J; Guo Y; Wang X; Yeow M; Wu AGR; Fuks D; Soubrane O; Dokmak S; Gruttadauria S; Zimmitti G; Ratti F; Kato Y; Scatton O; Herman P; Aghayan DL; Marino MV; Croner RS; Mazzaferro V; Chiow AKH; Sucandy I; Ivanecz A; Choi SH; Lee JH; Gastaca M; Vivarelli M; Giuliante F; Ruzzenente A; Yong CC; Yin M; et alii...

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2023 Dec 1;9(12):1651-1659. doi: 10.1001/jamaoncol.2023.4003.
2023
AO Ordine Mauriziano

Qin S; Kudo M; Meyer T; Bai Y; Guo Y; Meng Z; Satoh T; Marino D; Assenat E; Li S; Chen Y; Boisserie F; Abdrashitov R; Finn RS; Vogel A; Zhu AX;